Failure of oral zinc supplementation in atopic eczema

C. I. Ewing; A. C C Gibbs; C. Ashcroft; T. J. David

Failure of oral zinc supplementation in atopic eczema

C. I. Ewing, A. C C Gibbs, C. Ashcroft, T. J. David

Research output: Contribution to journal › Article › peer-review

Abstract

An eight week double-blind placebo-controlled trial of oral zinc sulphate 185.4 mg per day was undertaken in 50 children with atopic eczema aged 1-16 years. In those receiving zinc there was no significant improvement in disease severity as assessed by surface area affected and degree of erythema, symptom scores of itch, sleep disturbance and redness of skin, or weight of emollient or topical steroid use.

Original language	English
Pages (from-to)	507-510
Number of pages	3
Journal	European Journal of Clinical Nutrition
Volume	45
Issue number	10
Publication status	Published - 1991

Cite this

@article{4ab86c55c7e8466490506467cbc55b96,

title = "Failure of oral zinc supplementation in atopic eczema",

abstract = "An eight week double-blind placebo-controlled trial of oral zinc sulphate 185.4 mg per day was undertaken in 50 children with atopic eczema aged 1-16 years. In those receiving zinc there was no significant improvement in disease severity as assessed by surface area affected and degree of erythema, symptom scores of itch, sleep disturbance and redness of skin, or weight of emollient or topical steroid use.",

author = "Ewing, {C. I.} and Gibbs, {A. C C} and C. Ashcroft and David, {T. J.}",

year = "1991",

language = "English",

volume = "45",

pages = "507--510",

journal = "European Journal of Clinical Nutrition",

issn = "0954-3007",

publisher = "Springer Nature",

number = "10",

}

TY - JOUR

T1 - Failure of oral zinc supplementation in atopic eczema

AU - Ewing, C. I.

AU - Gibbs, A. C C

AU - Ashcroft, C.

AU - David, T. J.

PY - 1991

Y1 - 1991

N2 - An eight week double-blind placebo-controlled trial of oral zinc sulphate 185.4 mg per day was undertaken in 50 children with atopic eczema aged 1-16 years. In those receiving zinc there was no significant improvement in disease severity as assessed by surface area affected and degree of erythema, symptom scores of itch, sleep disturbance and redness of skin, or weight of emollient or topical steroid use.

AB - An eight week double-blind placebo-controlled trial of oral zinc sulphate 185.4 mg per day was undertaken in 50 children with atopic eczema aged 1-16 years. In those receiving zinc there was no significant improvement in disease severity as assessed by surface area affected and degree of erythema, symptom scores of itch, sleep disturbance and redness of skin, or weight of emollient or topical steroid use.

M3 - Article

C2 - 1782922

SN - 0954-3007

VL - 45

SP - 507

EP - 510

JO - European Journal of Clinical Nutrition

JF - European Journal of Clinical Nutrition

IS - 10

ER -

Failure of oral zinc supplementation in atopic eczema

Abstract

Fingerprint

Cite this